Free weekly newsletter
Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Arcutis Biotherapeutics Appoints David Topper As Chief Financial Officer
PUBLIC · ARQTApr 10, 2024•about 2 years ago
Company
Arcutis
Description
Arcutis Biotherapeutics, Inc. announced the appointment of David Topper as Chief Financial Officer (CFO), effective April 10, 2024, to replace John Smither. Frank Watanabe, president and CEO of Arcutis, expressed his pleasure in welcoming David to the organization and acknowledged John's contributions.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months